ISSN: 2167-065X

Pharmacologie clinique et biopharmaceutique

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Novel Approaches for Breast Cancer Screening and Treatment: A Review

Lynn Mouawad

Latest statistics proved breast cancer being the second leading cause of death in women in the world, which has led to an increase in public awareness for early screening and detection in order to reduce breast cancer death cases. Since the last two decades, many advances have emerged regarding its screening and treatments resulting in more efficient, less toxic results, and fewer death rates. This review paper highlights the different types of breast cancer, its different screening strategies such as mammography the gold standard technique and biosensors a new emerging device, and the different kind of treatments such as surgery, radiotherapy (non-drug therapy), chemotherapy, nanotechnology integration, or gene replacement therapy (drug-therapy).